Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Pediatric Gastroenterology and Nutrition|October 29, 2003
Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type IaAnne Marfaing-Koka, Martine Wolf, Catherine Boyer-Neumann, et al.Gynecologic and Obstetric Investigation|April 22, 2015
Safety of therapeutic doses of tinzaparin during pregnancyFlorence Parent, Philippe Deruelle, Olivier Sanchez, et al.Arthritis and Rheumatism|October 12, 2004
Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndromeZahir Amoura, Nathalie Costedoat-Chalumeau, Agnès Veyradier, et al.Critical Care (London, England)|November 19, 2013
The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulationVincent Peigne, Elie Azoulay, Isaline Coquet, et al.Blood|May 2, 2012
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpuraMarie Moatti-Cohen, Céline Garrec, Martine Wolf, et al.Thrombosis Research|February 26, 2010
Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in FranceAudrey Bidet, Brigitte Tardy Poncet, Dominique Desprez, et al.Blood|June 4, 2005
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 casesFadi Fakhouri, Jean-Paul Vernant, Agnès Veyradier, et al.Blood|December 14, 2006
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activitySilvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, et al.Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.Medicine|July 3, 2004
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvementPaul Coppo, Djaouida Bengoufa, Agnès Veyradier, et al.Pageof 2